Rovin Capital’s ProShares Ultra MSCI EAFE EFO Stock Holding History

Rovin Capital’s Portfolio EFO Stock Details EFO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$350K	Buy	5,471 +69	+1%	+$4.23K	0.09%	155
2025 Q3	$322K	Buy	5,402 +158	+3%	+$9.06K	0.09%	167
2025 Q2	$296K	Sell	5,244 -244	-4%	-$12.3K	0.09%	165
2025 Q1	$258K	Sell	5,488 -507	-8%	-$23.5K	0.08%	162
2024 Q4	$246K	Buy	5,995 +1,111	+23%	+$50K	0.09%	148
2024 Q3	$247K	Buy	4,884 +61	+1%	+$2.89K	0.09%	153
2024 Q2	$219K	Buy	+4,823	New	+$222K	0.09%	155

Other funds holding EFO

DWS

Discipline Wealth Solutions Greenville, South Carolina $1.15B AUM 20.96% 1-Year Est. Return

TWP

Tempus Wealth Planning Irvine, California $511M AUM 28.39% 1-Year Est. Return

PCA

PMV Capital Advisers Dallas, Texas $59.3M AUM 19.1% 1-Year Est. Return

EFG

Elm3 Financial Group Alpharetta, Georgia $146M AUM 30.79% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Rovin Capital's EFO Position: Q4 2025 in Review

Rovin Capital increased its ProShares Ultra MSCI EAFE (EFO) stake by 1.3% in Q4 2025, buying an estimated $4.23K and bringing the position to 5,471 shares worth $350K. The position accounts for 0.09% of the portfolio, ranked #155.

Rovin Capital first reported a position in EFO in Q2 2024 and has held it in 7 quarters since. 7 funds tracked by Wall St. Rank hold EFO as of Q4 2025.

Rovin Capital held 5,471 shares of ProShares Ultra MSCI EAFE worth $350K as of Q4 2025.
Rovin Capital bought 69 ProShares Ultra MSCI EAFE shares in Q4 2025, an estimated $4.23K.
ProShares Ultra MSCI EAFE made up 0.09% of Rovin Capital's portfolio in Q4 2025, its #155 holding.
Rovin Capital first reported a position in ProShares Ultra MSCI EAFE in Q2 2024 and has held it in 7 quarters since.
7 funds tracked by Wall St. Rank held ProShares Ultra MSCI EAFE as of Q4 2025.

Based on Rovin Capital's 13F filing for Q4 2025, filed 9 Feb 2026.